fbpx Skip to main content
 

Search

Janssen Search

Search results

652 SEARCH RESULTS FOR

research-development

Not finding what you're looking for? Visit Janssen in your country.
PAGE 6 OF 66

Pages

As Head of Technology at the Janssen Prevention Center, Anthony Williamson has broad responsibility for acquiring and developing innovative technologies for preventing non-communicable diseases. He brings to this role an impressive track record for ...

Can Artificial Intelligence Change How We Discover New Medicines? Sep 04, 2018 The big question right now is: Can artificial intelligence – also known as AI- change how scientist discover new medicines? Yes- According to new research from scientists at ...

Developing New Treatments for Neglected Tropical Diseases We Recognize the Urgent Need for Innovative Treatment Options In 2012, Johnson & Johnson signed the London Declaration on Neglected Tropical Diseases, a multilateral partnership to eliminate or ...

  Development Investing in ways to improve the diagnosis gap and improve survival rates. At Janssen, we are committed to addressing the diagnostic gap and improving survival rates. We have undertaken extensive research to map out the patient journey in ...

Article Type:  Infectious Diseases & Vaccines Tackling Infectious Diseases in China For several years Janssen has partnered with Tsinghua University in Beijing, China to host a Public Health Day that featured academia, leading government officials and ...

ALISON CHALKER, PH.D. PORTFOLIO STRATEGY & DATA SCIENCES INTEGRATION LEADER As Strategic Portfolio and Data Sciences Integration Leader for Neuroscience at Janssen Research & Development (R&D), Alison Chalker, Ph.D. leads a team responsible ...

Our Vision to Eliminate Prostate Cancer through a Multi-Pronged Approach   Prostate cancer is the second most common cancer and the fourth leading cause of cancer death in men worldwide, with an incidence of approximately 1.4 million and mortality of ...

Our Team: Leading the Fight Against Cancer At Janssen Oncology, we share a deep passion for scientific innovation and for bringing together the best expertise worldwide to make promising treatments available to patients who are waiting for them. Our ...

LLOYD S. MILLER, M.D., PH.D. VICE PRESIDENT IMMUNODERMATOLOGY DISEASE AREA LEADER Lloyd S. Miller, M.D., Ph.D., is Vice President, Immunodermatology Disease Area Leader for the Immunology Therapeutic Area at Janssen Research & Development, LLC. In ...

BEVERLY L. HARRISON SENIOR DIRECTOR PATIENT SUPPORT Beverly Harrison is responsible for leading the Patient Support Group reporting directly to the Chief Medical Officer at Janssen R&D, the research arm of Johnson & Johnson, focusing on developing ...

652 SEARCH RESULTS FOR

research-development

Not finding what you're looking for? Visit Janssen in your country.
PAGE 6 OF 66

Pages